醫療事務聲譽（美國）：異位性皮膚炎

本報告基於美國皮膚科醫生的回饋，分析了支持異位性皮膚炎藥物的醫療事務團隊的競爭力和聲譽。報告深入分析了醫生與醫療事務團隊的互動方式、哪些服務最重要、各產品的滿意度以及醫生偏好的溝通管道和頻率。報告還指出了醫療事務團隊需要加強能力的領域，以便在未來的治療環境中更好地滿足醫生的需求。

關鍵問題

• 1.醫師與醫療事務團隊的互動頻率如何？這種頻率是增加了還是減少了？
• 2.醫師目前如何利用醫療事務團隊提供的服務？
• 3.哪些醫療事務支援對醫師最重要？他們對這種支持的滿意度如何？
• 4.醫師喜歡如何與醫療事務團隊互動？他們喜歡多久互動一次？
• 5.醫學事務團隊如何滿足醫師的需求？
• 6.對於特定品牌，醫學事務團隊的表現是否超出預期或低於預期？
• 7.如何改善醫學事務服務，以便未來能更好地滿足醫師的需求？
• 8.競爭對手的醫學事務團隊有哪些優點和缺點？

領導品牌

This report examines the competitive performance and reputation of Medical Affairs teams supporting therapies for atopic dermatitis, based on feedback from dermatologists in the US. It provides detailed insights into how physicians currently engage with Medical Affairs teams, the services they value most, satisfaction levels by product, and preferred channels and frequency of interaction. The findings also highlight areas where Medical Affairs teams can strengthen their support to better meet physician needs in an evolving treatment landscape.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.